Despite low specificity routine mammography is the method of choice to
screen women for breast cancer. In addition high frequency ultrasonog
raphy (US) or magnetic resonance imaging (MRI) can improve breast canc
er diagnosis. However there is a lack of conventional imaging to impro
ve the high rate of false positive results that make biopsy or surgery
necessary. Aim: The purpose of our study was to evaluate prospectivel
y the sensitivity specificity, PPV and NPV of scintimammography with a
new cationic complex Tc-99m-tetrofosmin. Methods: Fourtyeight patient
s in whom mammography and/or high resolution ultrasonography (10MHz) r
evealed suspicious breast lesions were studied with Tc-99m-tetrofosmin
scintimammography. In thirtyfour of them biopsy and/or surgery was pe
rformed for histological evaluation. After intravenous injection of 55
5 MBq Tc-99m-tetrofosmin dynamic images over three minutes (1 frame/10
sec.) planar images in anterior and lateral projections (5 min. p.i.)
and SPECT imaging including 3-D-reconstruction (20 min. p.i.) were pe
rformed. Scintimammography was evaluated as negative, equivocal (+), p
robably (++) or definitely (+++) positive. Results: Scintimammography
with Tc-99m-tetrofosmin was negative in 18 patients (17 t.n.; 1 f.n.)
and positive in 16 patients (10 t.p., 6 f.p.). The false negative scin
timammography was observed in a patient with infiltrating ductal carci
noma pT1, the false positive result in a patient with fibrocystic dise
ase; all of the five fibroadenomas were also ''false'' positive. Sensi
tivity of Tc-99m-tetrofosmin scintimammography in this prospective stu
dy was 91%, specificity 74%, PPV 63% and NPV 94%. Scintimammographic r
esults in patients with suspicious breast lesion show, that Tc-99m-tet
rofosmin accumulates in breast cancer as well as in fibroadenoma. Howe
ver the high NPV of 94% excludes breast cancer in suspicious mammograp
hic lesions in a very high degree and therefore reduces the need of bi
opsy and/or surgery in most of these patients. Conclusion: Our first r
esults show that scintimammography with Tc-99m-tetrofosmin might play
a role as further diagnostic step before surgery for women in whom mam
mography and/or ultrasonography show suspicious lesions.